Dashboard
Manage Tickers

KPTI Karyopharm Therapeutics Inc.

Nasdaq karyopharm.com


$ 5.98 $ -0.10 (-1.66 %)    

Friday, 17-Oct-2025 15:56:46 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 5.93
$ 6.03
$ 5.50 x 4,000
$ 6.11 x 500
$ 5.76 - $ 6.03
$ 3.51 - $ 16.95
49,886
na
51.42M
$ 1.36
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
2 05-12-2025 03-31-2025 10-Q
3 02-19-2025 12-31-2024 10-K
4 11-05-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-29-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-17-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-24-2021 12-31-2020 10-K
20 11-02-2020 09-30-2020 10-Q
21 08-04-2020 06-30-2020 10-Q
22 05-05-2020 03-31-2020 10-Q
23 02-26-2020 12-31-2019 10-K
24 11-04-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-15-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 03-16-2017 12-31-2016 10-K
36 11-07-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

this-palo-alto-networks-analyst-turns-bullish-here-are-top-5-upgrades-for-monday
This Palo Alto Networks Analyst Turns Bull...
10/13/2025 11:48:50

hc-wainwright--co-upgrades-karyopharm-therapeutics-to-buy-announces-15-price-target
HC Wainwright & Co. Upgrades Karyopharm Th...
10/13/2025 11:23:41

HC Wainwright & Co. analyst Robert Burns upgrades Karyopharm Therapeutics (NASDAQ:KPTI) from Neutral to Buy and announce...

piper-sandler-reiterates-overweight-on-karyopharm-therapeutics-lowers-price-target-to-12
Piper Sandler Reiterates Overweight on Kar...
10/09/2025 14:17:44

Piper Sandler analyst Edward Tenthoff reiterates Karyopharm Therapeutics (NASDAQ:KPTI) with a Overweight and lowers the pric...

baird-maintains-outperform-on-karyopharm-therapeutics-lowers-price-target-to-21
Baird Maintains Outperform on Karyopharm T...
10/09/2025 12:08:17

Baird analyst Michael Ulz maintains Karyopharm Therapeutics (NASDAQ:KPTI) with a Outperform and lowers the price target from...

karyopharm-strengthens-balance-sheet-with-100-million-financing-to-extend-cash-runway-into-2026
Karyopharm Strengthens Balance Sheet With ...
10/08/2025 17:31:59

Karyopharm secures $100 million financing, extends cash runway into 2026, projects $42 million–$44 million Q3 revenue, and adva...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/08/2025 12:09:23

karyopharm-therapeutics-says-top-line-data-from-phase-3-sentry-trial-in-myelofibrosis-on-track-for-march-2026
Karyopharm Therapeutics Says Top-Line Data...
10/08/2025 11:27:39

karyopharm-therapeutics-expects-q3-preliminary-total-revenue-of-42m---44m-and-us-xpovio-net-product-revenue-of-32m
Karyopharm Therapeutics Expects Q3 Prelimi...
10/08/2025 11:23:17

karyopharm-therapeutics-says-top-line-data-from-phase-3-sentry-trial-in-myelofibrosis-is-on-track-for-march-2026
Karyopharm Therapeutics Says Top-Line Data...
10/08/2025 11:07:03

karyopharm-secures-100m-of-financial-flexibility-and-additional-capital-to-extend-cash-runway-into-q2-2026
Karyopharm Secures $100M Of Financial Flex...
10/08/2025 11:04:44

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/24/2025 21:06:04

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/23/2025 17:06:52

karyopharm-completes-enrollment-in-phase-3-trial-testing-new-combo-therapy-for-myelofibrosis-patients
Karyopharm Completes Enrollment In Phase 3...
09/10/2025 11:02:57

Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today ...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
09/08/2025 21:07:27

baird-maintains-outperform-on-karyopharm-therapeutics-lowers-price-target-to-25
Baird Maintains Outperform on Karyopharm T...
08/12/2025 11:41:22

Baird analyst Michael Ulz maintains Karyopharm Therapeutics (NASDAQ:KPTI) with a Outperform and lowers the price target from...

karyopharm-therapeutics-affirms-fy2025-sales-guidance-of-140m-155m-vs-145358m-est
Karyopharm Therapeutics Affirms FY2025 Sal...
08/11/2025 11:34:06

2025 Financial OutlookBased on its current operating plans, Karyopharm expects the following for full year 2025:Total revenue t...

karyopharm-therapeutics-q2-eps-432-misses-412-estimate-sales-37929m-beat-36770m-estimate
Karyopharm Therapeutics Q2 EPS $(4.32) Mis...
08/11/2025 11:32:34

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

earnings-outlook-for-karyopharm-therapeutics
Earnings Outlook For Karyopharm Therapeutics
08/08/2025 20:06:09

hc-wainwright--co-downgrades-karyopharm-therapeutics-to-neutral
HC Wainwright & Co. Downgrades Karyopharm ...
07/16/2025 11:35:51

HC Wainwright & Co. analyst Robert Burns downgrades Karyopharm Therapeutics (NASDAQ:KPTI) from Buy to Neutral.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION